284 related articles for article (PubMed ID: 30772864)
1. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
[TBL] [Abstract][Full Text] [Related]
2. Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation.
Olkinuora H; Käyhty H; Davidkin I; Roivainen M; Olander RM; Kantele JM; Siitonen S; Vettenranta K
Acta Paediatr; 2012 Aug; 101(8):e373-7. PubMed ID: 22537137
[TBL] [Abstract][Full Text] [Related]
3. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
[TBL] [Abstract][Full Text] [Related]
4. Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
Macková J; Hainz P; Kryštofová J; Roubalová K; Šťastná-Marková M; Vaníková Š; Musil J; Vydra J; Němečková Š
Leuk Res; 2023 Jul; 130():107314. PubMed ID: 37216792
[TBL] [Abstract][Full Text] [Related]
5. The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients.
Rol ML; Venet F; Rimmele T; Moucadel V; Cortez P; Quemeneur L; Gardiner D; Griffiths A; Pachot A; Textoris J; Monneret G;
BMJ Open; 2017 Jun; 7(6):e015734. PubMed ID: 28637738
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
Hilgendorf I; Freund M; Jilg W; Einsele H; Gea-Banacloche J; Greinix H; Halter J; Lawitschka A; Wolff D; Meisel R
Vaccine; 2011 Apr; 29(16):2825-33. PubMed ID: 21345379
[TBL] [Abstract][Full Text] [Related]
7. Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?
Conrad A; Alcazer V; Valour F; Ader F;
Expert Rev Vaccines; 2018 Apr; 17(4):299-309. PubMed ID: 29561216
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
[TBL] [Abstract][Full Text] [Related]
9. Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center.
Gouveia-Alves F; Gouveia R; Ginani VC; Seber A; Kuramoto DA; Murad GFA; Spina FG; Petrilli AS; Zecchin VG; Granato C; Carlesse F; de Moraes-Pinto MI
Transpl Infect Dis; 2018 Aug; 20(4):e12903. PubMed ID: 29668078
[TBL] [Abstract][Full Text] [Related]
10. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients.
Kawamura K; Yamazaki R; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
Hematology; 2015 Mar; 20(2):77-82. PubMed ID: 24992512
[TBL] [Abstract][Full Text] [Related]
12. A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant.
Miller PDE; de Silva TI; Leonard H; Anthias C; Hoschler K; Goddard K; Peggs K; Madrigal A; Snowden JA
Vaccine; 2019 Jan; 37(3):452-457. PubMed ID: 30554797
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian Infants: a randomised trial.
Odusanya OO; Kuyinu YA; Kehinde OA; Francois N; Yarzabal JP; Moreira M; Borys D; Schuerman L
Niger Postgrad Med J; 2013 Dec; 20(4):272-81. PubMed ID: 24633268
[TBL] [Abstract][Full Text] [Related]
14. Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study.
Jiménez-Jorge S; Labrador-Herrera G; Rosso-Fernández CM; Rodríguez-Torres N; Pachón-Ibáñez ME; Smani Y; Márquez-Malaver FJ; Limón Ramos C; Solano C; Vázquez-López L; Kwon M; Mora Barrios JM; Aguilar-Guisado M; Espigado I;
BMJ Open; 2020 Jul; 10(7):e034570. PubMed ID: 32690735
[TBL] [Abstract][Full Text] [Related]
15. Poor response to hepatitis A vaccination in hematopoietic stem cell transplant recipients.
Adati EM; da Silva PM; Sumita LM; Rodrigues MO; Zanetti LP; Dos Santos ACF; de Souza MP; Colturato VR; Machado CM
Transpl Infect Dis; 2020 Jun; 22(3):e13258. PubMed ID: 32034983
[TBL] [Abstract][Full Text] [Related]
16. Torque Teno Virus Viral Load as a Marker of Immune Function in Allogeneic Haematopoietic Stem Cell Transplantation Recipients.
Mouton W; Conrad A; Bal A; Boccard M; Malcus C; Ducastelle-Lepretre S; Balsat M; Barraco F; Larcher MV; Fossard G; Labussière-Wallet H; Ader F; Brengel-Pesce K; Trouillet-Assant S; Heminf Study Group L
Viruses; 2020 Nov; 12(11):. PubMed ID: 33187285
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM
Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177
[TBL] [Abstract][Full Text] [Related]
18. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
[TBL] [Abstract][Full Text] [Related]
19. Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review.
L'Huillier AG; Kumar D
Hum Vaccin Immunother; 2015; 11(12):2852-63. PubMed ID: 26291740
[TBL] [Abstract][Full Text] [Related]
20. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation.
van der Velden AM; Claessen AM; van Velzen-Blad H; de Groot MR; Kramer MH; Biesma DH; Rijkers GT
Vaccine; 2007 Dec; 25(51):8512-7. PubMed ID: 17996989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
